期刊文献+

支气管肺泡灌洗液(1,3)-β-D葡聚糖检测对重症患者侵袭性肺部真菌感染的疗效评价 被引量:3

Value of β-(1-3)-D-glucan in bronchoalveolar lavage fluid in evaluation of therapeeutic effects of invasive pulmonary fungal infection
下载PDF
导出
摘要 目的研究支气管肺泡灌洗液(BALF)G试验在对治疗危重症患者侵袭性肺部真菌感染(IPFI)疗效评估的价值。方法选取2012年6月1日~2014年6月1日期间东莞东华医院重症医学科临床诊断IPFI患者,对所有入选病例使用抗真菌药物进行抢先治疗,分别在治疗后第3天,第7天,第10天,第14天留取支气管肺泡灌洗液BALFG试验、留取血液标本做血清G试验。对其进行回顾性研究,根据临床转归情况分有效组与无效组,分别比较两组在不同治疗时间点留取的标本与治疗前BALFG试验、血清G试验结果。结果治疗后G试验结果变化与疗效有明显的关系。在治疗有效组中,无论BALFG试验还是血清G试验结果均较治疗前有所下降;而在无效组中,BALFG试验及血清G试验结果均有所上升。治疗3aM,在治疗有效组中,BALFG试验较治疗前留取的标本检验结果差异有统计学意义,P〈0.05;血清G试验结果较治疗前比较,差异无统计学意义。结论BALF的G试验能有效提高对IPFI患者治疗的疗效评估的敏感性,对协助侵袭性真菌感染患者的诊治过程的疗效评价乃致对治疗措施的作出及时合理调整起到较大指导作用。 Objective To study the therapeutic evaluation of bronchoalveolar lavage fluid (BALF) G-test in the treatment of invasive pulmonary fungal infections (IPFI) . Methods Thirty-nine patients in ICU diagnosed as with IPFI underwent treatment with antifungal drugs and divided into 2 groups according to the clinical manisfestation: effective group (n=30) and non-effective grou (n=9). BALF and blood samples were collected before treatment, and 3, 7, 10, and 14 days after treatment respectively to underego detection of β-(1-3)-D-glucan by restrospective analysis method. Results In the effective group, the BALF levels 3 days later were significantly lower than those before treatrment and then coninued to decrease (all P 〈0.05), but there was no significant differences in the serum [^-(1-3)-D-glucan levels 3 days later than those before treatment (all P 〉0.05). Conclusion BALF G test helps diagnose IPFI and evaluate the curative effect thereof.
出处 《中国急救复苏与灾害医学杂志》 2015年第6期555-557,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 肺泡灌洗液 (1 3)-β—D葡聚糖 侵袭性肺部真菌感染 危重症 Alveolar lavage fluid β-(1-3)-D-glucan Invasive pulmonary fungal infection
  • 相关文献

参考文献4

二级参考文献22

  • 1朱小敏,周新.侵袭性肺曲霉病的诊断与治疗[J].中国呼吸与危重监护杂志,2005,4(4):316-320. 被引量:36
  • 2Verweij PE, Figueroa J, van Burik J, et al. Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses[J]. Med My col,2000,38 (Suppl 1) :161-171.
  • 3Hope WW, Walsh TJ,Dennlng DW. Laboratory diagnosi s of invasive aspergillosis[J]. Lancet Infect Dis, 2005,5 (10) : 609- 622.
  • 4Ikemura K, Ikegami K,Shimazu T,et al. False-positive result in Limulus test caused hy Limulus amebocyte lysate-reactive material in immunoglobulin products[J]. J Clin Microbiol, 1989,27(9) : 1965-1968.
  • 5Takaki Y, Seki N, Kawabata Si S,et al. Duplicated binding sites for (1,3)-beta-D-glucan in the horseshoe crab coagulation factor G:implications for a molecular basis of the patternrecognition in innate immunity[J]. J Biol Chem, 2002,277 (16) :14281-14287.
  • 6Odabasi Z, Mattiuzzi G, Estey E, et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation,cutoff development,and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome[J]. C1]n Infect Dis, 2004,39(2) : 199-205.
  • 7Tanaka S, Aketagawa J, Takahashi S, et al. Inhibition of highmolecular-weight-( 1, 3 )-beta-d-glucan-dependent activation of a limulus coagulation factor G by laminaran oligosaccharides and curdlan degradation products[J]. Carbohydr Res, 1993,244(1) :115-127.
  • 8Pazos C,Ponton J,Del Palocio A. Contribution of (1,3)-β-D glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neurpenic adult patients: a comparison with serial screening for circulating galactomannan[J]. J Clin Microbiol,2005,43 ( 1 ) : 299-305.
  • 9Picketing JW, Sant HW,Bowles CA, et al. Evaluation of a (1,3)-β-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol, 2005,43 (12) : 5957-5962.
  • 10Obayashi T, Yoshida M, Mori T, et al. Plasma (1,3)-β-D-glucan in diagnosis of invasive deep mycosis and fungal febrile epidoses[J]. Lancet, 1995,345 (8941) . 17-20.

共引文献488

同被引文献23

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部